Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.
ISBN: | 9781482231694 |
Publication date: | 20th December 2016 |
Author: | Kerry B Barker |
Publisher: | Chapman & Hall/CRC an imprint of CRC Press |
Format: | Hardback |
Pagination: | 248 pages |
Series: | Chapman & Hall/CRC Biostatistics Series |
Genres: |
Epidemiology and Medical statistics Pharmacology Probability and statistics Biology, life sciences |